CVS Health Corporation $CVS Shares Newly Acquired by Hohimer Wealth Management LLC

Hohimer Wealth Management LLC purchased a new stake in shares of CVS Health Corporation (NYSE:CVS) in the third quarter, HoldingsChannel.com reports. The institutional investor purchased 44,290 shares of the pharmacy operator’s stock, valued at approximately $3,795,000.

Several other institutional investors have also added to or reduced their stakes in CVS. University of Texas Texas AM Investment Management Co. boosted its position in shares of CVS Health by 7,527.1% during the 3rd quarter. University of Texas Texas AM Investment Management Co. now owns 46,754 shares of the pharmacy operator’s stock valued at $4,006,000 after acquiring an additional 46,141 shares during the last quarter. Almanack Investment Partners LLC. raised its stake in CVS Health by 23.1% during the third quarter. Almanack Investment Partners LLC. now owns 2,562 shares of the pharmacy operator’s stock valued at $220,000 after purchasing an additional 481 shares in the last quarter. M Holdings Securities Inc. purchased a new stake in CVS Health during the third quarter valued at $890,000. Brighton Jones LLC lifted its position in CVS Health by 7.5% during the third quarter. Brighton Jones LLC now owns 19,160 shares of the pharmacy operator’s stock valued at $1,642,000 after purchasing an additional 1,339 shares during the last quarter. Finally, American State Bank Iowa lifted its position in CVS Health by 9.5% during the third quarter. American State Bank Iowa now owns 3,834 shares of the pharmacy operator’s stock valued at $329,000 after purchasing an additional 333 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insider Transactions at CVS Health

In other news, EVP Prem Shah acquired 23,855 shares of the firm’s stock in a transaction on Friday, November 6th. The stock was acquired at an average price of $83.89 per share, with a total value of $2,001,195.95. Following the completion of the purchase, the executive vice president directly owned 88,516 shares in the company, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.85% of the stock is currently owned by insiders.

CVS Health Trading Down 0.1%

CVS stock opened at $83.76 on Monday. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. CVS Health Corporation has a twelve month low of $69.51 and a twelve month high of $110.68. The stock has a market capitalization of $107.17 billion, a price-to-earnings ratio of 9.75, a price-to-earnings-growth ratio of 0.73 and a beta of 0.58. The firm’s fifty day simple moving average is $90.37 and its two-hundred day simple moving average is $88.89.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.65 by $0.44. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The firm had revenue of $108.40 billion during the quarter, compared to analyst estimates of $104.72 billion. During the same quarter last year, the business earned $1.60 EPS. The business’s revenue was up 5.4% on a year-over-year basis. As a group, analysts anticipate that CVS Health Corporation will post 8.25 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were given a $0.6650 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.2%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s dividend payout ratio is 30.97%.

Analyst Ratings Changes

CVS has been the topic of a number of research reports. Wells Fargo & Company boosted their target price on shares of CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. BMO Capital Markets set a $112.00 price target on shares of CVS Health in a report on Wednesday, September 9th. Truist Financial lifted their price target on CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Cantor Fitzgerald reissued a “neutral” rating on shares of CVS Health in a research note on Friday, October 9th. Finally, Wall Street Zen downgraded CVS Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, October 19th. Twenty-two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $108.25.

Trending Headlines about CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
• Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
• Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
• Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

CVS Health Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.